日本語View as Markdown

Spinal peroxynitrite contributes to remifentanil-induced postoperative hyperalgesia via enhancement of divalent metal transporter 1 without iron-responsive element-mediated iron accumulation in rats.

ラットにおけるレミフェンタニル誘発術後痛覚過敏に対する脊髄ペルオキシナイトライトの関与:鉄応答配列非依存性DMT1を介した鉄蓄積機序の検討

animal study injection / infusion positive

Abstract

This rat study examined the mechanism underlying postoperative hyperalgesia following remifentanil-based intraoperative analgesia. Thermal and mechanical hyperalgesia developed at 48 hours post-surgery. In spinal cord tissue, levels of 3-nitrotyrosine (1.22 ± 0.18 vs. 0.25 ± 0.05), nitrated manganese superoxide dismutase (1.01 ± 0.1 vs. 0.19 ± 0.03), and DMT1(-)IRE expression (1.42 ± 0.19 vs. 0.33 ± 0.06) were markedly elevated, along with iron concentration (12.87 ± 1.14 vs. 5.26 ± 0.61 μg/g), while DMT1(+)IRE remained unchanged. Administration of hydrogen-rich saline, which selectively decomposes peroxynitrite, reduced DMT1(-)IRE overexpression, attenuated iron accumulation, and alleviated hyperalgesia. An iron chelator also suppressed hyperalgesia in a dose-dependent fashion, supporting the role of iron in this nociceptive process.

Mechanism

Spinal peroxynitrite upregulates DMT1(-)IRE, causing abnormal iron accumulation that promotes NMDA-mediated neurotoxicity and postoperative hyperalgesia. Hydrogen-rich saline selectively scavenges peroxynitrite, thereby suppressing DMT1(-)IRE overexpression and reducing iron-dependent nociceptive signaling.

Bibliographic

Authors
Shu RC, Zhang LL, Wang CY, Li N, Wang H, Xie K, et al.
Journal
Anesthesiology
Year
2015
PMID
25501899
DOI
10.1097/ALN.0000000000000562

Tags

Disease:脊髄損傷 Delivery:点滴投与 Mechanism:炎症抑制 ミトコンドリア 酸化ストレス ペルオキシナイトライト消去 活性酸素種

Delivery context

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

Safety notes

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 25501899. https://h2-papers.org/en/papers/25501899
Source: PubMed PMID 25501899